Table 3 Comparison of cases and controls for candidate biomarkers according to stage, grade, node status, NPI and HER2 status

From: Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples

 

Stage

Grade

Node status

NPI

HER2 status

Marker

Ctrl vs 1/2

Ctrl vs 3/4

Ctrl vs 1

Ctrl vs 2

Ctrl vs 3

Ctrl vs N0

Ctrl vs N1

Ctrl vs 4

Ctrl vs >4

Ctrl vs neg

Ctrl vs pos

(A) All samples

CA15-3

NS

0.0215

0.0254

NS

NS

NS

NS

NS

NS

NS

NS

RANTES

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

OPN

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

IGFBP3

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

PAI-1

NS

NS

NS

NS

0.0491

NS

NS

NS

NS

NS

NS

HSP90A

NS

NS

NS

NS

0.0174

NS

NS

NS

0.0196

ns

ns

SLPI

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

PAPPA

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

APOC1

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

(B) <1.15 years to D x

CA15-3

NS

NS

NS

NS

NS

NS

0.0419

NS

NS

NS

NS

RANTES

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

OPN

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

IGFBP3

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

PAI-1

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

HSP90A

NS

NS

NS

NS

NS

NS

NS

0.0259

0.0419

NS

NS

SLPI

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

PAPPA

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

APOC1

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

(C) >1.15 years to D x

CA15-3

NS

NS

0.039

NS

NS

NS

NS

NS

NS

NS

NS

RANTES

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

OPN

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

IGFBP3

NS

NS

NS

NS

NS

NS

0.0447

NS

NS

NS

NS

PAI-1

NS

NS

NS

NS

NS

NS

NS

NS

NS

0.0391

0.0364

HSP90A

NS

NS

NS

NS

0.0079

NS

NS

NS

NS

NS

NS

SLPI

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

PAPPA

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

APOC1

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

  1. P-values for various comparisons are shown. P<0.05 was considered significant; NS denotes non-significance. Comparisons are shown for all pre-diagnosis case samples vs all controls (A), between case samples taken <1.15 years to diagnosis (median) and all controls (B) and between case samples taken >1.15 years to diagnosis and all controls (C).